Two for one? CAR-T therapy for lymphoma benefits concurrent autoimmune disorders

[PDF] oup.com

Chimeric antigen receptor T cell therapy: a new emerging landscape in autoimmune rheumatic diseases

X Lyu, L Gupta, E Tholouli, H Chinoy - Rheumatology, 2024 - academic.oup.com
Chimeric antigen receptor T cell (CAR-T) therapy, an innovative immune cell therapy, has
revolutionized the treatment landscape of haematological malignancies. The past 2 years …
被引用次数：2 相关文章 所有 5 个版本

Chimeric antigen receptors:“CARs” in the fast lane for rheumatology

NM Johnson, F Koumpouras - Current Opinion in Rheumatology, 2024 - journals.lww.com
Chimeric antigen receptors: “CARs” in the fast lane for rheu... : Current Opinion in
Rheumatology Chimeric antigen receptors: “CARs” in the fast lane for rheumatology …
相关文章 所有 5 个版本

Expanding the role of CAR T‐cell therapy: From B‐cell hematological malignancies to autoimmune rheumatic diseases

R Shumnalieva, T Velikova… - International Journal of …, 2024 - Wiley Online Library
Chimeric antigen receptor (CAR) T‐cell therapy is a form of immunotherapy where the
lymphocytes, mostly T‐cells, are redirected to specifically recognize and eliminate a target …
相关文章 所有 2 个版本